Synthetic people are proving surprisingly useful
From chatbots to clinical trials, digital twins are suggesting at least one good answer to the question of what generative AI is for
From chatbots to clinical trials, digital twins are suggesting at least one good answer to the question of what generative AI is for
PLUS: What I got right (and wrong) about 2025
The US is retaliating against the EU after it fined X — and now some of Europe's biggest companies are caught in the crossfire
A fresh investigation reveals the scope of Meta's problem in China. Will a pending court case force the company to crack down — or destroy Section 230?
A decade years in, what started as a sci-fi lab is now focused on engagement and growth. What does that mean for building AI safely?